Expert Forum on Chronic Lymphocytic Leukemia is organized by Oncology Meeting Innovations (OMI) and will be held from Jul 26 - 27, 2019 at Dallas, Texas, United States Of America.
Key Topics:
• Debate the rapidly expanding information on molecular diagnostics, genomic analysis, new molecular targets, and the evolution of care over the next five years of CLL treatment
• Deliberate risk assessment and integration of MRD into clinical trials
• Debate BTK, PI3K, and BCL2 inhibitors and how they can be used in combination therapy, how to prevent resistance, and
• how emerging inhibitors compete
• Explore the role of CAR-T cells therapy in CLL
• Discuss the integration of novel therapies, including checkpoint inhibitors, antibody drug conjugates, and bispecific antibodies, into the current treatment paradigm
• Explore new targets in development for CLL.
Additional details will be posted as soon as they are available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved